India, Jan. 15 -- Compagnie Financiere Richemont AG (CFR.SW,CFR.JO,CFRUY,CFRHF), a Swiss luxury goods company, on Thursday reported a rise in sales for the third quarter, helped by the performance of ... Read More
India, Jan. 15 -- The Netherlands' unemployment rate held steady for the third straight month in December, data from the Central Bureau of Statistics showed on Thursday. The seasonally adjusted ILO j... Read More
India, Jan. 15 -- Santhera Pharmaceuticals (SANN.SW,SPHDF) announced that the Swiss Agency for Therapeutic Products (Swissmedic) has approved AGAMREE (vamorolone) for the treatment of Duchenne muscula... Read More
India, Jan. 15 -- Sanofi Winthrop Industrie announced that China's National Medical Products Administration (NMPA) has granted approval for two innovative Sanofi-licensed medicines. Myqorzo (aficamten... Read More
India, Jan. 15 -- VAT Group AG (19V.F,VACN.SW) reported preliminary fourth-quarter sales of 257 million Swiss francs, ahead of the guidance range of 225 to 245 million francs. Fourth-quarter sales dec... Read More
India, Jan. 15 -- Geberit AG (GBERY.PK,GBERF.PK), a Swiss maker of sanitary products and related systems, reported Thursday higher sales in its fourth quarter and fiscal 2025, significantly above mark... Read More
India, Jan. 15 -- Velan Inc. (VLN.TO) announced that its controlling shareholder, Velan Holding, the sole holder of the company's multiple voting shares, has agreed to sell its 15,566,567 multiple vot... Read More
India, Jan. 15 -- European stocks look set to open broadly higher on Thursday after U.S. President Donald Trump said Iran has stayed executions of protesters, signaling he may hold off on attacking th... Read More
India, Jan. 14 -- BP Plc (BP) said its reported upstream production in the fourth quarter is expected to be broadly flat compared to the prior quarter, with production broadly flat in oil production &... Read More
India, Jan. 14 -- Neuren Pharmaceuticals Ltd. (NURPF.OB,NEU.AX) Wednesday said that global net sales of DAYBUE, its prescription drug for Rett syndrome, is expected to touch $700 million in 2028. The ... Read More